Phase 2 Kidney Transplant Clinical Trials
15 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–15 of 15 trials
Recruiting
Phase 2
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
Kidney Transplant Recipients
University Health Network, Toronto20 enrolled1 locationNCT05938712
Recruiting
Phase 2
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Kidney Transplantation
Singulera Therapeutics Inc.34 enrolled7 locationsNCT06552169
Recruiting
Phase 2Phase 3
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
Kidney Transplant Rejection
Sanofi526 enrolled10 locationsNCT07412470
Recruiting
Phase 2
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB10 enrolled5 locationsNCT05753930
Recruiting
Phase 2
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Kidney Transplant; Complications
University of North Carolina, Chapel Hill100 enrolled1 locationNCT06059664
Recruiting
Phase 1Phase 2
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
Kidney TransplantationXenotransplantationESRD (End-Stage Renal Disease)
United Therapeutics50 enrolled2 locationsNCT06878560
Recruiting
Phase 2
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID)800 enrolled15 locationsNCT05917522
Recruiting
Phase 2
Advancing Transplantation Outcomes in Children
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled20 locationsNCT06055608
Recruiting
Phase 2
Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID)180 enrolled4 locationsNCT06919003
Recruiting
Phase 1Phase 2
The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients
Kidney TransplantationDelayed Graft Function
First Affiliated Hospital of Chongqing Medical University47 enrolled2 locationsNCT07275632
Recruiting
Phase 1Phase 2
Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
Kidney TransplantationXenotransplantationESRD (End-Stage Renal Disease)
United Therapeutics50 enrolled1 locationNCT07224763
Recruiting
Phase 1Phase 2
Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Kidney TransplantToleranceRenal Transplant Rejection
Jeffrey Veale, MD15 enrolled1 locationNCT03707262
Recruiting
Phase 1Phase 2
CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
Kidney Transplant; ComplicationsCMV
University of Minnesota30 enrolled1 locationNCT07096453
Recruiting
Phase 1Phase 2
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Prevention of Rejection in Kidney Transplant
Eledon Pharmaceuticals48 enrolled9 locationsNCT05027906
Recruiting
Phase 2
Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
Kidney Transplantation
TolerogenixX GmbH126 enrolled8 locationsNCT05365672